NCT06027372 Heart Rate Variability and Nocturnal Blood Oxygen Saturation in Patients With Idiopathic Pulmonary Fibrosis Status UNKNOWN Phase N/A
NCT06003426 A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Idiopathic Pulmonary Fibrosis Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT05984992 The First-in-human Study of SRN-001 in Healthy Participants Status COMPLETED Phase PHASE1
NCT05983471 Efficacy and Safety of ME-015 (Suplatast Tosilate) in Cough Related to Idiopathic Pulmonary Fibrosis (COSMIC-IPF) Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT05976217 Safety and Efficacy of Venetoclax in Idiopathic Pulmonary Fibrosis Status COMPLETED Phase EARLY_PHASE1
NCT05954988 A Study to Evaluate LTI-03 in Newly Diagnosed Idiopathic Pulmonary Fibrosis (IPF) Patients Status COMPLETED Phase PHASE1
NCT05912049 A Study to Evaluate the Safety, Tolerability, Pharmacokinetic Properties and Immunogenicity of 9MW3811 in Healthy Subjects Status UNKNOWN Phase PHASE1
NCT05870956 Burden of Nintedanib Non-adherence Among Idiopathic Pulmonary Fibrosis (IPF) Patients Status COMPLETED Phase N/A
NCT05863091 Respiratory Rate Validation Study - HiCardi+ Wearable Patch Device, Mezoo Co., Ltd. Status UNKNOWN Phase NA
NCT05842681 Azithromycin in the Management of Patients With Acute Exacerbation of Idiopathic Pulmonary Fibrosis Status RECRUITING Phase NA
NCT05817240 A Drug-Drug Interaction Study of ENV-101 (Taladegib) on Nintedanib Pharmacokinetics in Healthy Subjects Status COMPLETED Phase PHASE1
NCT05785624 A Study Evaluating the Efficacy and Safety of Vixarelimab in Participants With Idiopathic Pulmonary Fibrosis and in Participants With Systemic Sclerosis-Associated Interstitial Lung Disease Status TERMINATED Phase PHASE2
NCT05784207 An In Silico Trial to Evaluate Prospectively the Performance of a Radiomics Algorithm for UIP Compared to Medical Doctors Status COMPLETED Phase N/A
NCT05779007 Dose Reduction and Discontinuation With Anti-Fibrotic Medications Status COMPLETED Phase N/A
NCT05755308 Faecal Microbiota Transplantation to Ameliorate Nintedanib-induced Diarrhea in Patients With Idiopathic Pulmonary Fibrosis Status NOT_YET_RECRUITING Phase NA
NCT05722964 Study on Intravenous Injection of SHR-1906 in the Treatment of Idiopathic Pulmonary Fibrosis Status COMPLETED Phase PHASE2